P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdu165.213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Adjuvant Therapy in Stage II Colon Cancer: Current Approaches

Oncologist
Cancer ResearchMedicineOncology
2005English

Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine

Clinical Colorectal Cancer
OncologyGastroenterology
2017English

Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial

British Journal of Cancer
Cancer ResearchOncology
2012English

2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy

Scripta Scientifica Medica
2015English

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70

PLoS ONE
Multidisciplinary
2015English

Role of Adjuvant Therapy in Resected Stage IA Subcentimeter (T1a/T1b) Pancreatic Cancer

Cancer
Cancer ResearchOncology
2018English

Considering Adjuvant Therapy for Stage II Melanoma

Cancer
Cancer ResearchOncology
2019English

Adjuvant Chemotherapy for Stage II Right-Sided and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data

Annals of Surgical Oncology
OncologySurgery
2014English

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy